Efficacy of Bicalutamide 150-mg Monotherapy Compared With Combined Androgen Blockade in Patients With Locally Advanced Prostate Cancer

PURPOSE: We compared the efficacy, survival rate, and adverse events between bicalutamide 150-mg monotherapy and combined androgen blockade (CAB) in men with locally advanced prostate cancer. MATERIALS AND METHODS: From March 2003 to July 2012, we retrospectively included 74 patients who were treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yu Jin, Kim, Ki Ho, Lee, Kyung Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026657/
https://www.ncbi.nlm.nih.gov/pubmed/24868335
http://dx.doi.org/10.4111/kju.2014.55.5.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026657/
https://www.ncbi.nlm.nih.gov/pubmed/24868335
http://dx.doi.org/10.4111/kju.2014.55.5.315

Ejemplares similares